Contact your GP, specialist, or clinical trial team promptly if you experience: A spreading rash , hives (urticaria), or widespread skin redness that develops after starting treatment Swelling of the face, lips, tongue, or throat , which may indicate angioedema a potentially serious allergic reaction requiring urgent assessment Difficulty breathing or swallowing alongside skin changes call 999 immediately , as this could indicate anaphylaxis Signs of infection at an injection site , including increasing warmth, pus, significant swelling, or fever Persistent or worsening skin symptoms that do not improve with basic self-care measures after one to two weeks Unexplained bruising or bleeding beyond what would be expected from a subcutaneous injection If you are unsure whether your symptoms require urgent attention, NHS 111 can provide guidance
Madej, The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
No template protocols
Collins, CO 720-818-0533
Endorsed by global authorities like ASMBS and NIH as the most effective treatment for severe obesity
Chronic Weight Management Research is underway on Retatrutides potential role in long-term weight management
